₹154.90
₹-0.15 (-0.10%)
Closed · As of 26 Aug 3:30 pm
Mkt Cap
₹136 Cr
P/E
10.46
ROE
18.31%
ROCE
18.42%
About Speciality Medicines Ltd
Speciality Medicines are engaged in the business of marketing and distribution of finished formulations of specialty pharmaceutical products, comprising of high-cost oral and injectable medications used in the treatment of complex and chronic medical conditions in therapeutic areas like oncology, immunology, neurology and rare diseases.
Founded
2021
CEO
Parth B Goyani
Employees
18
HQ
Mumbai, India
About Speciality Medicines Ltd
Speciality Medicines are engaged in the business of marketing and distribution of finished formulations of specialty pharmaceutical products, comprising of high-cost oral and injectable medications used in the treatment of complex and chronic medical conditions in therapeutic areas like oncology, immunology, neurology and rare diseases.
Founded:2021
CEO:Parth B Goyani
Employees:18
HQ:Mumbai, India
Finished Products
1Sale of Products
₹85.80CrRaw Materials
1Purchase of Stock-in-Trade
₹73.16CrPrice Performance & Market EventsPrice Performance
Loading chart data…
Key Metrics
Trading & valuation snapshot
52W High
₹381
52W Low
₹121
Volume1.00K
Avg VolumeN/A
BetaN/A
Dividend Yield0.00%
Key Financial Ratios
Profitability, leverage & efficiency at a glance
P/E Ratio
10.46x
Valuation
P/B Ratio
1.91x
Valuation
EPS
₹14.83
Valuation
Dividend Yield
0.00%
Valuation
ROE
18.31%
Profitability
ROCE
18.42%
Profitability
Revenue by Segment
Contribution & growth by business line
No segment revenue data available
Geographical Revenue Split
Domestic vs international exposure
Domestic
0.0%
International
100.0%
Export sales69.1%
Domestic sales30.9%
Strategic Relations
Collaborations, joint ventures & subsidiaries
No collaborations data available.
Forensic Metrics
Financial health & earnings-quality indicators
Revenue Quality
N/A
Days Sales Outstanding
Leverage
0.09x
Debt-to-Equity
Earnings Quality
N/A
Cash Conversion Ratio
Efficiency
N/A
Asset Turnover
Earnings Quality
N/A
Accruals Ratio
Profitability
N/A
Gross Margin
Growth
35.9%
Sales Growth
These metrics are derived from available financial disclosures and market data. Use them together with company filings and qualitative analysis before making decisions.